Structural, Electronic, and Electrostatic Determinants for Inhibitor Binding to Subsites S1 and S2 in SARS-CoV-2 Main Protease
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Structural, Electronic, and Electrostatic Determinants for Inhibitor Binding to Subsites S1 and S2 in SARS-CoV-2 Main Protease
Authors
Keywords
-
Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 64, Issue 23, Pages 17366-17383
Publisher
American Chemical Society (ACS)
Online
2021-10-28
DOI
10.1021/acs.jmedchem.1c01475
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7
- (2021) Pengfei Wang et al. NATURE
- A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication
- (2021) Shin-ichiro Hattori et al. Nature Communications
- Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2 from Molecular Sculpting of the Drug Perampanel Guided by Free Energy Perturbation Calculations
- (2021) Chun-Hui Zhang et al. ACS Central Science
- On the origin and evolution of SARS-CoV-2
- (2021) Devika Singh et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Direct Observation of Protonation State Modulation in SARS-CoV-2 Main Protease upon Inhibitor Binding with Neutron Crystallography
- (2021) Daniel W. Kneller et al. JOURNAL OF MEDICINAL CHEMISTRY
- Expedited Approach toward the Rational Design of Noncovalent SARS-CoV-2 Main Protease Inhibitors
- (2021) Naoya Kitamura et al. JOURNAL OF MEDICINAL CHEMISTRY
- X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease
- (2021) Sebastian Günther et al. SCIENCE
- Nanobased Platforms for Diagnosis and Treatment of COVID-19: From Benchtop to Bedside
- (2021) Elham Bidram et al. ACS Biomaterials-Science & Engineering
- Mini-Review Discussing the Reliability and Efficiency of COVID-19 Vaccines
- (2021) Bogdan Doroftei et al. Diagnostics
- Structure-Based Optimization of ML300-Derived, Noncovalent Inhibitors Targeting the Severe Acute Respiratory Syndrome Coronavirus 3CL Protease (SARS-CoV-2 3CLpro)
- (2021) Sang Hoon Han et al. JOURNAL OF MEDICINAL CHEMISTRY
- 3CL Protease Inhibitors with an Electrophilic Arylketone Moiety as Anti-SARS-CoV-2 Agents
- (2021) Sho Konno et al. JOURNAL OF MEDICINAL CHEMISTRY
- Peptidomimetic α-Acyloxymethylketone Warheads with Six-Membered Lactam P1 Glutamine Mimic: SARS-CoV-2 3CL Protease Inhibition, Coronavirus Antiviral Activity, and in Vitro Biological Stability
- (2021) Bing Bai et al. JOURNAL OF MEDICINAL CHEMISTRY
- Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2
- (2021) Tia A. Tummino et al. SCIENCE
- Structure-guided design of a perampanel-derived pharmacophore targeting the SARS-CoV-2 main protease
- (2021) Maya G. Deshmukh et al. STRUCTURE
- Recent discovery and development of inhibitors targeting coronaviruses
- (2020) Thanigaimalai Pillaiyar et al. DRUG DISCOVERY TODAY
- A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV
- (2020) Jiabao Xu et al. Viruses-Basel
- Drug Development and Medicinal Chemistry Efforts toward SARS‐Coronavirus and Covid‐19 Therapeutics
- (2020) Arun K. Ghosh et al. ChemMedChem
- Rapid Identification of Potential Inhibitors of SARS‐CoV‐2 Main Protease by Deep Docking of 1.3 Billion Compounds
- (2020) Anh-Tien Ton et al. Molecular Informatics
- Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
- (2020) Zhenming Jin et al. NATURE
- Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
- (2020) Wenhao Dai et al. SCIENCE
- Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
- (2020) Linlin Zhang et al. SCIENCE
- Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
- (2020) Chunlong Ma et al. CELL RESEARCH
- The Development of Coronavirus 3C-Like Protease (3CLpro) Inhibitors from 2010 to 2020
- (2020) Yuzhi Liu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- SARS-CoV-2 Main Protease: A Molecular Dynamics Study
- (2020) Dimas Suárez et al. Journal of Chemical Information and Modeling
- Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography
- (2020) Daniel W. Kneller et al. Nature Communications
- Substrate Binding Stiffens Aspartate Aminotransferase by Altering the Enzyme Picosecond Vibrational Dynamics
- (2020) Steven Dajnowicz et al. ACS Omega
- The SARS-CoV-2 main protease as drug target
- (2020) Sven Ullrich et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Unusual zwitterionic catalytic site of SARS-CoV-2 main protease revealed by neutron crystallography
- (2020) Daniel W. Kneller et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19
- (2020) Robert L. Hoffman et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs
- (2020) Zhe Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Malleability of the SARS-CoV-2 3CL Mpro active site cavity facilitates binding of clinical antivirals
- (2020) Daniel W. Kneller et al. STRUCTURE
- Structural Basis of SARS-CoV-2 and SARS-CoV Antibody Interactions
- (2020) Edem Gavor et al. TRENDS IN IMMUNOLOGY
- Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2
- (2020) Mohammad M. Ghahremanpour et al. ACS Medicinal Chemistry Letters
- Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease
- (2020) Lifeng Fu et al. Nature Communications
- Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease
- (2020) Alice Douangamath et al. Nature Communications
- Room-temperature neutron and X-ray data collection of 3CL Mpro from SARS-CoV-2
- (2020) Daniel W. Kneller et al. Acta Crystallographica Section F-Structural Biology Communications
- Uncovering Flexible Active Site Conformations of SARS-CoV-2 3CL Proteases through Protease Pharmacophore Clusters and COVID-19 Drug Repurposing
- (2020) Nikhil Pathak et al. ACS Nano
- A Quick Route to Multiple Highly Potent SARS‐CoV‐2 Main Protease Inhibitors**
- (2020) Kai S. Yang et al. ChemMedChem
- Supercomputer-Based Ensemble Docking Drug Discovery Pipeline with Application to Covid-19
- (2020) A. Acharya et al. Journal of Chemical Information and Modeling
- Development of a virtual reality platform for effective communication of structural data in drug discovery
- (2019) Laura J. Kingsley et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- Current Developments in Coot for Macromolecular Model Building of Electron Cryo‐microscopy and Crystallographic Data
- (2019) Ana Casañal et al. PROTEIN SCIENCE
- A suite-level review of the neutron single-crystal diffraction instruments at Oak Ridge National Laboratory
- (2018) L. Coates et al. REVIEW OF SCIENTIFIC INSTRUMENTS
- Improving the accuracy and resolution of neutron crystallographic data by three-dimensional profile fitting of Bragg peaks in reciprocal space
- (2018) Brendan Sullivan et al. Acta Crystallographica Section D-Structural Biology
- An Overview of Severe Acute Respiratory Syndrome–Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy
- (2016) Thanigaimalai Pillaiyar et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Macromolecular Neutron Diffractometer MaNDi at the Spallation Neutron Source
- (2015) Leighton Coates et al. JOURNAL OF APPLIED CRYSTALLOGRAPHY
- How good are my data and what is the resolution?
- (2013) Philip R. Evans et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Overview of theCCP4 suite and current developments
- (2011) Martyn D. Winn et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease
- (2011) Lili Zhu et al. ANTIVIRAL RESEARCH
- Vibrational Softening of a Protein on Ligand Binding
- (2011) Erika Balog et al. JOURNAL OF PHYSICAL CHEMISTRY B
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- PHENIX: a comprehensive Python-based system for macromolecular structure solution
- (2010) Paul D. Adams et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Generalized X-ray and neutron crystallographic analysis: more accurate and complete structures for biological macromolecules
- (2009) Paul D. Adams et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- electronic Ligand Builder and Optimization Workbench(eLBOW): a tool for ligand coordinate and restraint generation
- (2009) Nigel W. Moriarty et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- MolProbity: all-atom structure validation for macromolecular crystallography
- (2009) Vincent B. Chen et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started